iA Global Asset Management Inc.

Position in ABBV — AbbVie Inc.

CIK 1969566 Quebec, A8

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$197,034

+$26,740 QoQ

Shares Held

783

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#3,965

of 4,153 holders

Holding Since

Jun 2023

13 quarters on record

Healthcare · as of Jun 30, 2026

iA Global Asset Management Inc. holds $187,071,908 across 8 Drug Manufacturers - General names. ABBV ranks #8 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	346,960	$88,117,431
2	LLY	ELI LILLY & Co	32,937	$39,505,629
3	AMGN	Amgen Inc	62,971	$22,803,058
4	GILD	Gilead Sciences, Inc.	148,928	$18,815,563
5	MRK	Merck & Co., Inc.	69,634	$8,947,969
6	BMY	Bristol Myers Squibb Co	142,925	$8,235,338
7	PFE	Pfizer Inc	18,683	$449,886
8	ABBV	AbbVie Inc. This page	783	$197,034

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$197,034	783	0.0%	Shares	Sole	2026-07-29
2026-03-31	$170,294	783	-57.7%	Shares	Sole	2026-04-23
2025-12-31	$422,706	1,850	-62.3%	Shares	Sole	2026-02-05
2025-09-30	$1,136,629	4,909	-4.2%	Shares	Sole	2025-10-30
2025-06-30	$951,302	5,125	+18.6%	Shares	Sole	2025-08-05
2025-03-31	$905,126	4,320	-73.4%	Shares	Sole	2025-05-09
2024-12-31	$2,883,182	16,225	-28.6%	Shares	Sole	2025-02-11
2024-09-30	$4,488,720	22,730	-74.9%	Shares	Sole	2024-11-15
2024-06-30	$15,524,275	90,510	+9.3%	Shares	Sole	2025-04-08
2024-03-31	$15,076,423	82,792	-7.2%	Shares	Sole	2025-04-08
2023-12-31	$13,827,198	89,225	-42.2%	Shares	Sole	2025-04-08
2023-09-30	$23,023,211	154,456	+4.9%	Shares	Sole	2025-04-08
2023-06-30	$19,839,935	147,257	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.